Sign inJoin waitlistJoin the waitlist

William Tester

Vice Chairman, Clinical Operations · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY

Credentials: · · · · · ·

History

SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present
Bladder Cancer Research · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present
SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present

MedStar Georgetown University Hospital
1980–1983
Internal Medicine
Albert Einstein Medical Center
1977–1980
Drexel University College of Medicine
1973–1977

Research

Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology…
Journal of Clinical Oncology · 2014 · 358 citations
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
Journal of Clinical Oncology · 2020 · 224 citations
Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802
Journal of Clinical Oncology · 1996 · First of 8 authors · 220 citations

Kevin Zarrabi
6 papers
Patrick Mille
6 papers
WS
William Shipley
6 papers
WK
Wm Kelly
6 papers
JS
Joan Schiller
5 papers
John Leighton
5 papers
Suresh Ramalingam
5 papers
HS
Howard Sandler
4 papers
MH
Michael Hagan
4 papers
Young Chae
4 papers
CB
Chandra Belani
3 papers
Costas Lallas
3 papers

Clinical trials

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2021–2027
TR(ACE) Assay Clinical Specimen Study
Site PI · Unknown
Biological Dynamics
2016–2018